img

Global Therapeutic Nuclear Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Nuclear Drug Market Insights, Forecast to 2034

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Market Analysis and InsightsGlobal Therapeutic Nuclear Drug Market
Global Therapeutic Nuclear Drug market is expected to reach to US$ 2036 million in 2024, with a positive growth of %, compared with US$ 1771 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Therapeutic Nuclear Drug industry is evaluated to reach US$ 4734 million in 2029. The CAGR will be 15.1% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Therapeutic Nuclear Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Therapeutic Nuclear Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application


Thyroid
Bone Metastasis
Lymphoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Therapeutic Nuclear Drug introduction, etc. Therapeutic Nuclear Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Therapeutic Nuclear Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Nuclear Drug Market Perspective (2018-2029)
2.2 Global Therapeutic Nuclear Drug Growth Trends by Region
2.2.1 Therapeutic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Nuclear Drug Historic Market Size by Region (2018-2024)
2.2.3 Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Nuclear Drug Market Dynamics
2.3.1 Therapeutic Nuclear Drug Industry Trends
2.3.2 Therapeutic Nuclear Drug Market Drivers
2.3.3 Therapeutic Nuclear Drug Market Challenges
2.3.4 Therapeutic Nuclear Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Therapeutic Nuclear Drug by Players
3.1.1 Global Therapeutic Nuclear Drug Revenue by Players (2018-2024)
3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2018-2024)
3.2 Global Therapeutic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Therapeutic Nuclear Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Therapeutic Nuclear Drug Market Concentration Ratio
3.4.1 Global Therapeutic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Drug Revenue in 2022
3.5 Global Key Players of Therapeutic Nuclear Drug Head office and Area Served
3.6 Global Key Players of Therapeutic Nuclear Drug, Product and Application
3.7 Global Key Players of Therapeutic Nuclear Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Nuclear Drug Breakdown Data by Type
4.1 Global Therapeutic Nuclear Drug Historic Market Size by Type (2018-2024)
4.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029)
5 Therapeutic Nuclear Drug Breakdown Data by Application
5.1 Global Therapeutic Nuclear Drug Historic Market Size by Application (2018-2024)
5.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Nuclear Drug Market Size (2018-2029)
6.2 North America Therapeutic Nuclear Drug Market Size by Type
6.2.1 North America Therapeutic Nuclear Drug Market Size by Type (2018-2024)
6.2.2 North America Therapeutic Nuclear Drug Market Size by Type (2024-2029)
6.2.3 North America Therapeutic Nuclear Drug Market Share by Type (2018-2029)
6.3 North America Therapeutic Nuclear Drug Market Size by Application
6.3.1 North America Therapeutic Nuclear Drug Market Size by Application (2018-2024)
6.3.2 North America Therapeutic Nuclear Drug Market Size by Application (2024-2029)
6.3.3 North America Therapeutic Nuclear Drug Market Share by Application (2018-2029)
6.4 North America Therapeutic Nuclear Drug Market Size by Country
6.4.1 North America Therapeutic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Therapeutic Nuclear Drug Market Size by Country (2018-2024)
6.4.3 North America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Therapeutic Nuclear Drug Market Size (2018-2029)
7.2 Europe Therapeutic Nuclear Drug Market Size by Type
7.2.1 Europe Therapeutic Nuclear Drug Market Size by Type (2018-2024)
7.2.2 Europe Therapeutic Nuclear Drug Market Size by Type (2024-2029)
7.2.3 Europe Therapeutic Nuclear Drug Market Share by Type (2018-2029)
7.3 Europe Therapeutic Nuclear Drug Market Size by Application
7.3.1 Europe Therapeutic Nuclear Drug Market Size by Application (2018-2024)
7.3.2 Europe Therapeutic Nuclear Drug Market Size by Application (2024-2029)
7.3.3 Europe Therapeutic Nuclear Drug Market Share by Application (2018-2029)
7.4 Europe Therapeutic Nuclear Drug Market Size by Country
7.4.1 Europe Therapeutic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Therapeutic Nuclear Drug Market Size by Country (2018-2024)
7.4.3 Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Therapeutic Nuclear Drug Market Size (2018-2029)
8.2 China Therapeutic Nuclear Drug Market Size by Type
8.2.1 China Therapeutic Nuclear Drug Market Size by Type (2018-2024)
8.2.2 China Therapeutic Nuclear Drug Market Size by Type (2024-2029)
8.2.3 China Therapeutic Nuclear Drug Market Share by Type (2018-2029)
8.3 China Therapeutic Nuclear Drug Market Size by Application
8.3.1 China Therapeutic Nuclear Drug Market Size by Application (2018-2024)
8.3.2 China Therapeutic Nuclear Drug Market Size by Application (2024-2029)
8.3.3 China Therapeutic Nuclear Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Therapeutic Nuclear Drug Market Size (2018-2029)
9.2 Asia Therapeutic Nuclear Drug Market Size by Type
9.2.1 Asia Therapeutic Nuclear Drug Market Size by Type (2018-2024)
9.2.2 Asia Therapeutic Nuclear Drug Market Size by Type (2024-2029)
9.2.3 Asia Therapeutic Nuclear Drug Market Share by Type (2018-2029)
9.3 Asia Therapeutic Nuclear Drug Market Size by Application
9.3.1 Asia Therapeutic Nuclear Drug Market Size by Application (2018-2024)
9.3.2 Asia Therapeutic Nuclear Drug Market Size by Application (2024-2029)
9.3.3 Asia Therapeutic Nuclear Drug Market Share by Application (2018-2029)
9.4 Asia Therapeutic Nuclear Drug Market Size by Region
9.4.1 Asia Therapeutic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Therapeutic Nuclear Drug Market Size by Region (2018-2024)
9.4.3 Asia Therapeutic Nuclear Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Therapeutic Nuclear Drug Introduction
11.1.4 Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Therapeutic Nuclear Drug Introduction
11.2.4 Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Details
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Introduction
11.3.4 China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.3.5 China Isotope & Radiation Recent Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Details
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Therapeutic Nuclear Drug Introduction
11.4.4 Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.4.5 Dongcheng Recent Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Details
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Therapeutic Nuclear Drug Introduction
11.5.4 Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.5.5 Q BioMed Recent Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Details
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Introduction
11.6.4 Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.6.5 Curium Pharmaceuticals Recent Developments
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Details
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Therapeutic Nuclear Drug Introduction
11.7.4 Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.7.5 Jubilant Radiopharma Recent Developments
11.8 Lantheus
11.8.1 Lantheus Company Details
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Therapeutic Nuclear Drug Introduction
11.8.4 Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.8.5 Lantheus Recent Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Details
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Therapeutic Nuclear Drug Introduction
11.9.4 Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.9.5 Aurobindo Pharma Recent Developments
11.10 International Isotopes
11.10.1 International Isotopes Company Details
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Therapeutic Nuclear Drug Introduction
11.10.4 International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.10.5 International Isotopes Recent Developments
11.11 Mundipharma
11.11.1 Mundipharma Company Details
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Therapeutic Nuclear Drug Introduction
11.11.4 Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2024)
11.11.5 Mundipharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Therapeutic Nuclear Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Therapeutic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Therapeutic Nuclear Drug Market Share by Region (2018-2024)
Table 10. Global Therapeutic Nuclear Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Therapeutic Nuclear Drug Market Share by Region (2024-2029)
Table 12. Therapeutic Nuclear Drug Market Trends
Table 13. Therapeutic Nuclear Drug Market Drivers
Table 14. Therapeutic Nuclear Drug Market Challenges
Table 15. Therapeutic Nuclear Drug Market Restraints
Table 16. Global Therapeutic Nuclear Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Therapeutic Nuclear Drug Revenue Share by Players (2018-2024)
Table 18. Global Top Therapeutic Nuclear Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Table 19. Global Therapeutic Nuclear Drug Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Therapeutic Nuclear Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Therapeutic Nuclear Drug, Headquarters and Area Served
Table 22. Global Key Players of Therapeutic Nuclear Drug, Product and Application
Table 23. Global Key Players of Therapeutic Nuclear Drug, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2018-2024)
Table 27. Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Therapeutic Nuclear Drug Revenue Share by Application (2018-2024)
Table 31. Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Therapeutic Nuclear Drug Revenue Share by Application (2024-2029)
Table 33. North America Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Therapeutic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Therapeutic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Therapeutic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Therapeutic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Therapeutic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Therapeutic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Therapeutic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Therapeutic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Therapeutic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Therapeutic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Therapeutic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Therapeutic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Therapeutic Nuclear Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Therapeutic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Therapeutic Nuclear Drug Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Therapeutic Nuclear Drug Product
Table 68. Bayer Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 69. Bayer Recent Developments
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Therapeutic Nuclear Drug Product
Table 73. Novartis Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 74. Novartis Recent Developments
Table 75. China Isotope & Radiation Company Details
Table 76. China Isotope & Radiation Business Overview
Table 77. China Isotope & Radiation Therapeutic Nuclear Drug Product
Table 78. China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 79. China Isotope & Radiation Recent Developments
Table 80. Dongcheng Company Details
Table 81. Dongcheng Business Overview
Table 82. Dongcheng Therapeutic Nuclear Drug Product
Table 83. Dongcheng Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 84. Dongcheng Recent Developments
Table 85. Q BioMed Company Details
Table 86. Q BioMed Business Overview
Table 87. Q BioMed Therapeutic Nuclear Drug Product
Table 88. Q BioMed Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 89. Q BioMed Recent Developments
Table 90. Curium Pharmaceuticals Company Details
Table 91. Curium Pharmaceuticals Business Overview
Table 92. Curium Pharmaceuticals Therapeutic Nuclear Drug Product
Table 93. Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 94. Curium Pharmaceuticals Recent Developments
Table 95. Jubilant Radiopharma Company Details
Table 96. Jubilant Radiopharma Business Overview
Table 97. Jubilant Radiopharma Therapeutic Nuclear Drug Product
Table 98. Jubilant Radiopharma Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 99. Jubilant Radiopharma Recent Developments
Table 100. Lantheus Company Details
Table 101. Lantheus Business Overview
Table 102. Lantheus Therapeutic Nuclear Drug Product
Table 103. Lantheus Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 104. Lantheus Recent Developments
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Therapeutic Nuclear Drug Product
Table 108. Aurobindo Pharma Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 109. Aurobindo Pharma Recent Developments
Table 110. International Isotopes Company Details
Table 111. International Isotopes Business Overview
Table 112. International Isotopes Therapeutic Nuclear Drug Product
Table 113. International Isotopes Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 114. International Isotopes Recent Developments
Table 115. Mundipharma Company Details
Table 116. Mundipharma Business Overview
Table 117. Mundipharma Therapeutic Nuclear Drug Product
Table 118. Mundipharma Revenue in Therapeutic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 119. Mundipharma Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Therapeutic Nuclear Drug Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Therapeutic Nuclear Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Therapeutic Nuclear Drug Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Therapeutic Nuclear Drug Report Years Considered
Figure 14. Global Therapeutic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Therapeutic Nuclear Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Therapeutic Nuclear Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Therapeutic Nuclear Drug Market Share by Players in 2022
Figure 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Therapeutic Nuclear Drug Revenue in 2022
Figure 20. North America Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Therapeutic Nuclear Drug Market Share by Type (2018-2029)
Figure 22. North America Therapeutic Nuclear Drug Market Share by Application (2018-2029)
Figure 23. North America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 24. United States Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Therapeutic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Therapeutic Nuclear Drug Market Share by Type (2018-2029)
Figure 28. Europe Therapeutic Nuclear Drug Market Share by Application (2018-2029)
Figure 29. Europe Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 30. Germany Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Therapeutic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Therapeutic Nuclear Drug Market Share by Type (2018-2029)
Figure 38. China Therapeutic Nuclear Drug Market Share by Application (2018-2029)
Figure 39. Asia Therapeutic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Therapeutic Nuclear Drug Market Share by Type (2018-2029)
Figure 41. Asia Therapeutic Nuclear Drug Market Share by Application (2018-2029)
Figure 42. Asia Therapeutic Nuclear Drug Market Share by Region (2018-2029)
Figure 43. Japan Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Therapeutic Nuclear Drug Market Share by Country (2018-2029)
Figure 53. Brazil Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Therapeutic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 60. Novartis Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 61. China Isotope & Radiation Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 62. Dongcheng Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 63. Q BioMed Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 64. Curium Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 65. Jubilant Radiopharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 66. Lantheus Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 67. Aurobindo Pharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 68. International Isotopes Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 69. Mundipharma Revenue Growth Rate in Therapeutic Nuclear Drug Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries